Search Results - subject:"Inhibitors"

Impact of Gastrointestinal Problems on Adherence to Low-Dose Acetylsalicylic Acid: A Quantitative Study in Patients with Cardiovascular Risk

Moberg, Christina; Naesdal, Jrgen; Svedberg, Lars-Erik; … - In: The Patient: Patient-Centered Outcomes Research 4 (2011) 2, pp. 103-113

Background: Low-dose acetylsalicylic acid (ASA; 75-325 mg) is a mainstay of therapy for patients at high risk of cardiovascular (CV) events. However, in some patients, such treatment is associated with upper gastrointestinal (GI) adverse effects, e.g. dyspeptic symptoms, peptic ulceration, and...

Persistent link: https://www.econbiz.de/10011005087

Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma

Mohamed, Ateesha F.; Hauber, A. Brett.; Neary, Maureen P. - In: PharmacoEconomics 29 (2011) 11, pp. 977-988

Background: Angiogenesis inhibitor agents have been shown to be effective in increasing progression-free survival (PFS) in patients with renal cell carcinoma (RCC); however, these treatments have different toxicity profiles. Objective: Our objective was to quantify patients' benefit-risk...

Persistent link: https://www.econbiz.de/10010614374

Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan

Yeh, Hseng-Long; Huang, Li-Ying; Su, Syi; Yang, Ming-Chin; … - In: Health Policy 100 (2011) 2, pp. 196-202

National guidelines recommend angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs …

Persistent link: https://www.econbiz.de/10010573169

Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece

Maniadakis, Nikos; Ekman, Mattias; Fragoulakis, Vasilios; … - In: The European Journal of Health Economics 12 (2011) 3, pp. 253-261

Persistent link: https://www.econbiz.de/10009149813

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume I: Summary

Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002

-hypertensive: the ACE inhibitors. The results of these morbidity models should be seen as tentative, until these results can be …

Persistent link: https://www.econbiz.de/10005763258

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume III: ACE and CCB Literature Review

Dolovich, Lisa R.; Holbrook, Anne M.; Woodruff, Margaret - Department of Economics, McMaster University - 2002

(see SEDAP 70 for abstract)

Persistent link: https://www.econbiz.de/10005763264

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume III: ACE and CCB Literature Review

Dolovich, Lisa R.; Holbrook, Anne M.; Woodruff, Margaret - Department of Economics, McMaster University - 2002

(see QSEP 369 for abstract)

Persistent link: https://www.econbiz.de/10005181106

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume I: Summary

Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002

-hypertensive: the ACE inhibitors. The results of these morbidity models should be seen as tentative, until these results can be …

Persistent link: https://www.econbiz.de/10005181109

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume II: Technical Report

Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002

(see QSEP 369 for abstract)

Persistent link: https://www.econbiz.de/10005181110

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume II: Technical Report

Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002

(see SEDAP 70 for abstract)

Persistent link: https://www.econbiz.de/10005404416